Dr Kokayi takes a look at the present treatment options for COVID-19 and highlights the importance of informed consent with respect to the experimental vaccine. Dr Kokayi brings into focus another narrative that has been created by a group of medical Academics and specialists who have documented another route for people to address COVID-19 , both prophylaxis and treatment. In addition the efforts to discredit hydroxychloroquine in this country are highlighted with reference to observational results of some of the better results being experienced in countries where hydroxychloroquine has been recommended. Ivermectin as an important treatment option is highlighted. Dr Kokayi directs his comments toward reviewing some of the research around vitamin D3 and the insistence by many that this nutrient be taken to minimize the impact of COVID-19 symptoms.
- Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers Anshul Jain, Rachna Chaurasia, Narendra Singh Sengar, Mayank Singh, Sachin,Mahor & SumitNarain
- Scientific Reports volume 10, Article number: 20191 (2020)
Vitamin D level is markedly low in severe COVID-19 patients. Inflammatory response is high in vitamin D deficient COVID-19 patients. This all translates into increased mortality in vitamin D deficient COVID-19 patients. As per the flexible approach in the current COVID-19 pandemic authors recommend mass administration of vitamin D supplements to population at risk for COVID-19.
- Vitamin D and COVID-19: Why the Controversy?
Lancet Diabetes and Endocrinology: Published: January 11, 2021 Read the article…The COVID-19 pandemic has further escalated the discussion. It has long been clear that groups that traditionally exhibit vitamin D deficiency or insufficiency, such as older adults and nursing home residents, and Black, Asian, and minority ethnic populations, are the same groups that have also been disproportionately impacted by COVID-19. Additionally, increased time spent indoors due to strict lockdowns and shielding triggered concerns that some people might not obtain the necessary physiological levels of vitamin D from sunlight.
- Op-Ed: Don’t Let COVID 19 Patients Die With Vitamin D Deficiency
- We Can’t Wait for Perfect Evidence by Richard H. Carmona, MD, MPH, Vatsal G. Thakkar, MD, and John C. Umhau, MD, MPH January 5, 2021
- Medpage TodayIt is our responsibility as physicians not to wait for perfect evidence when making life-and-death decisions. Given the safety profile of vitamin D, the 40% prevalence of vitamin D deficiency in the U.S., and the fact that this season will likely be the deadliest phase of the pandemic to date, we need to act now. Identifying and eradicating vitamin D deficiency with early and aggressive supplementation in COVID-19 has the potential to save thousands of lives and should be one of our highest public health priorities.
- Experts send Vitamin D and Covid-19 open letter to world’s governments
21-Dec-2020 By Nikki Hancocks
“In an open letter being sent to world governments today (21st December), 120 health, science and medical experts from the UK, US, and Europe say there is clear scientific evidence that vitamin D reduces Covid-19 infections, hospitalizations, and deaths.”
- COVID-19: Scientists raise the vitamin D alarm
02-Oct-2020 By Nikki Hancocks
”A group of researchers and doctors have formed an international alliance aiming to encourage governments to increase recommendations for vitamin D intake to 4,000 IU daily as they believe this would reduce COVID-19 hospitalizations.”
- Vitamin D Deficiency in COVID-19 Quadrupled Death Rate, by Becky McCall
“Vitamin D deficiency on admission to hospital was associated with a 3.7-fold increase in the odds of dying from COVID-19, according to an observational study looking back at data from the first wave of the pandemic”
- Vitamin D and COVID-19: evidence and recommendations for supplementation
George Griffin, Martin Hewison, Julian Hopkin, Rose Kenny, Richard Quinton, Jonathan Rhodes
Sreedhar Subramanian, and David Thickett
Published:01 December 2020
Royal Society Open Science
“Adults likely to be deficient should consider taking a higher dose, e.g. 4000 IU/day for the first four weeks before reducing to 800 IU–1000 IU/day. People admitted to the hospital with COVID-19 should have their vitamin D status checked and/or supplemented and consideration should be given to testing high-dose calcifediol in the RECOVERY trial. We feel this should be pursued with great urgency. Vitamin D levels in the UK will be falling from October onwards as we head into winter. There seems nothing to lose and potentially much to gain.”
- America’s Front Line Doctors